Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$55,393,769
+$8,417,568 QoQ
Shares Held
226,615
-0.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 44.562118845261104.ToString("F0")%
Shared 0.ToString("F0")%
None 55.437881154738896.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$244
CallShares
1
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Orion Porfolio Solutions, LLC holds $221,310,249 across 15 Drug Manufacturers - General names. JNJ ranks #1 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
226,615 | $55,393,769 | |
| 2 | LLY |
ELI LILLY & Co
|
51,627 | $47,484,964 | |
| 3 | ABBV |
AbbVie Inc.
|
138,202 | $30,057,552 | |
| 4 | AZN |
Astrazeneca PLC
|
80,263 | $15,829,467 | |
| 5 | MRK |
Merck & Co., Inc.
|
124,118 | $14,930,153 | |
| 6 | PFE |
Pfizer Inc
|
446,491 | $12,537,466 | |
| 7 | AMGN |
Amgen Inc
|
27,190 | $9,566,800 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
68,638 | $9,566,077 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $244 | 1 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $55,393,769 | 226,615 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $46,976,201 | 226,993 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $39,250,076 | 211,682 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $32,506,116 | 212,806 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $33,793,050 | 203,769 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $28,795,722 | 199,113 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $32,701,763 | 201,788 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $28,680,392 | 196,226 | Shares | Sole | 2025-07-31 | |
| 2024-03-31 | $31,461,776 | 198,886 | Shares | Sole | 2025-07-31 | |
| 2023-12-31 | $31,334,833 | 199,916 | Shares | Sole | 2025-07-31 | |
| 2023-09-30 | $34,241,170 | 219,847 | Shares | Sole | 2025-07-31 | |
| 2023-06-30 | $41,237,487 | 249,139 | Shares | Sole | 2025-07-31 | |
| 2022-12-31 | $30,783,029 | 174,260 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $29,870,049 | 182,848 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $33,409,867 | 188,214 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $37,432,393 | 211,208 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $35,634,736 | 208,305 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $29,803,209 | 184,540 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $30,455,813 | 184,872 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $30,110,891 | 183,212 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $21,787,372 | 138,438 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $28,128,196 | 188,932 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $1,155,275 | 8,215 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||